What is Palvella Therapeutics's net margin?

Palvella Therapeutics (PVLA) reported net margin of 71.7% in Q1 2024.

How has Palvella Therapeutics's net margin changed year-over-year?

Palvella Therapeutics's net margin increased by 129.2% year-over-year, from -245.5% to 71.7%.

What is the long-term trend for Palvella Therapeutics's net margin?

Over 3 years (2020 to 2023), Palvella Therapeutics's net margin has grown at a -29.9% compound annual growth rate (CAGR), from -127% to 43.7%.

What does net margin mean?

Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.

Palvella Therapeutics PVLA Net margin

Net margin at other companies

Relay Therapeutics, Inc.RLAY

-2,554.1%-745pp

Viridian Therapeutics, Inc.VRDN

-508.5%-254pp

ANI PharmaceuticalsANIP

10%+8.1pp

PrecigenPGEN

-3,656%—

Arcutis Biotherapeutics, Inc.ARQT

-13.9%-6.6pp

Ultragenyx PharmaceuticalRARE

-90.9%-2.1pp

Other financials

Income statement

See full

Revenue$53.0K-97.3%

Operating income-$14.9M-88.7%

Net income-$15.8M-92.6%

EPS (diluted)-$1.20-62.2%

Balance sheet

See full

Cash & equivalents$206.4M+173%

Total debt$584.0K—

Total equity$232.3M+318%

Total assets$263.8M+232%

Cash flow

See full

Operating cash flow-$10.9M-60.5%

CapEx--100%

Free cash flow-$2.7M+72.0%

Valuation

See full

Market cap$1.7B+468%

Enterprise value$1.5B—

P/S41.6×—

Profitability

See full

Operating margin-183.2%-13.5pp

FCF margin-99.8%-34.2pp

Returns & leverage

See full

Return on equity-34.2%—

Debt / equity0×—

Current ratio28.9×+20.0×

Where this comes from

Calculated from Palvella Therapeutics’s reported figures.

net income/total revenue=71.7%

Based on trailing twelve months.

The official record: Palvella Therapeutics’s 10-Q, filed May 15, 2024, on SEC EDGAR. View the filing →

Ask your AI about Palvella Therapeutics's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Palvella Therapeutics's net margin?: Palvella Therapeutics (PVLA) reported net margin of 71.7% in Q1 2024.
How has Palvella Therapeutics's net margin changed year-over-year?: Palvella Therapeutics's net margin increased by 129.2% year-over-year, from -245.5% to 71.7%.
What is the long-term trend for Palvella Therapeutics's net margin?: Over 3 years (2020 to 2023), Palvella Therapeutics's net margin has grown at a -29.9% compound annual growth rate (CAGR), from -127% to 43.7%.
What does net margin mean?: Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.